4-[(2,5,8,11,14,17,20,23,26,29-Decaoxahentriacontan-31-yl)oxy]benzaldehyde
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | m-PEGn-Ph-CHO |
| Catalog NO. | BPG-1465 |
| Product Name | 4-[(2,5,8,11,14,17,20,23,26,29-Decaoxahentriacontan-31-yl)oxy]benzaldehyde |
| Molecular Formula | C28H48O12 |
| Molecular Weight | 576.68 |
- Scheme Design
- Custom Synthesis
- cGMP Manufacturing
- Quality Assurance
- Product Information
- Documents
- Reviews
Product Information
| Description | 4-[(2,5,8,11,14,17,20,23,26,29-Decaoxahentriacontan-31-yl)oxy]benzaldehyde is a small molecule PEG linker containing a terminal benzaldehyde moiety that can react with primary amine groups. The PEG arm increases the solubility of compounds in aqueous media. |
| Synonyms | m-PEG11-Ph-CHO; m-PEG10-Ph-CHO |
| IUPAC Name | 4-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]benzaldehyde |
| SMILES | O=CC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)C=C1 |
| InChI | InChI=1S/C28H48O12/c1-30-6-7-31-8-9-32-10-11-33-12-13-34-14-15-35-16-17-36-18-19-37-20-21-38-22-23-39-24-25-40-28-4-2-27(26-29)3-5-28/h2-5,26H,6-25H2,1H3 |
| InChIKey | GYKSVGWXDATQDG-UHFFFAOYSA-N |
| Purity | ≥95% |
| Storage | Store at 2-8°C |
Reviews
If you have any suggestions or comments about 4-[(2,5,8,11,14,17,20,23,26,29-Decaoxahentriacontan-31-yl)oxy]benzaldehyde , please submit a review immediately.
Why BOC Sciences?
-
Large Stock
More than 2000+ products in inventory
-
Global Delivery
Warehouses in multiple cities to ensure fast delivery
-
mg to kg
Multi specification for academic research and industrial production
-
24/7 Technical Support
Strict process parameter control to ensure product quality
Our Feature
BOC Sciences supplies a unique variety of PEG derivatives and functional PEG polymers. Our products offer the most diverse collection of reactivity, ready-to-use functionality, and molecular weight options that you will not find anywhere else.
PEGylation of Peptides
and Proteins
Reduce the Immunogenicity of Peptide/Protein Drugs
Learn More
APPLICATIONS
PEG linkers For Drug
Improved Circulation Half-Life
Learn More
Have Customer
Reviewed On Us?
Chat With Us